SOPHiA GENETICS Launches Revolutionary AI-Powered Digital Twins for Oncology Decision-Making
SOPHiA GENETICS Introduces AI-Powered Digital Twins for Better Oncology Decision-Making
In a bold step towards revolutionizing oncology, SOPHiA GENETICS (Nasdaq: SOPH), a frontrunner in AI-driven precision medicine, has officially launched SOPHiA DDM™ Digital Twins—an innovative research technology. This tool creates dynamic virtual representations, or
Topics Other）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.